Explore the importance of histology and biomarker evaluation for oncology clinical trials.

Jessica Morris will discuss strategies to improve CAR-T cell targeting, activation, and killing capabilities.

Researchers use a mesenchymal stromal cell-based vector to deliver multiple viruses simultaneously to improve CAR-T cell anti-tumor activity.

The cancer researcher and executive vice president of AstraZeneca’s oncology research and development is well known for his role in the development of pivotal breast cancer therapies.

The oncologist developed lifesaving childhood leukemia treatments and revolutionized chemotherapy.

LuZhe Sun will discuss TGFβ signaling during cancer progression and how researchers can target this pathway.

Multiple next-generation sequencing (NGS) techniques offer insights into health and disease.

The findings may have implications for radiotherapy, a cancer treatment that can cause damage to salivary glands and leave lasting complications.

Daohong Zhou and Aileen Frost explore how they target the proteolysis mechanism and fight cancer using proteolysis targeting chimera (PROTAC) technology.

In this webinar brought to you by 10x Genomics, experts will discuss how to successfully prepare nuclei suspensions for Single Cell Multiome ATAC + Gene Expression experiments.

In this webinar brought to you by 10x Genomics, experts will discuss tips for running Chromium Single Cell Multiome ATAC + Gene Expression experiments in your lab.

Join us to learn about adoptive cell therapies from leading experts in the field of cancer immunology. 

Joseph Powell will discuss how heterogeneous subpopulations of HPV+ head and neck cancer cells drive unique disease states, cell-cell interactions, and microenvironment dynamics, and have implications for cancer behavior, metastasis, and response to treatment.   

Download this research summary to learn about how single-cell proteomics and metabolomics methods unlock drug resistance mechanisms!

Download this research summary to learn about functional proteomic adaptations leading to increased metastasis!

Mice that experienced heart attacks underwent a large-scale shift in their immune systems that allowed cancer to flourish, perhaps explaining the observation in patients.

A cancer researcher with a talent for leadership, Marks turned the Memorial Sloan Kettering Cancer Center into one of the world’s foremost oncology research institutions.

Calls to include a new breast cancer subtype in future clinical trials reveal fundamental disagreements about HER2’s role in the disease.

The Vanderbilt University professor was awarded a Nobel Prize for his discovery of epidermal growth factor.